
Tom Weaver, scientist, serial entrepreneur, and co-founder and chairman of CellCodex, discusses his career building biotechnology companies, the importance of translating scientific innovation into successful products, and the potential of AI-driven drug discovery to transform our ability to treat disease.
Our host, Grant Belgard, is also a co-founder and the CTO of CellCodex.
The Bioinformatics CRO serves the computational biology needs of academic researchers, nonprofits, and biotechnology and pharmaceutical companies.